Loading…
Loading…
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Singh, Neha, Miner, Alexandra, Hennis, Lauren, Mittal, Sandeep
Published in Cancer drug resistance (01.01.2021)
Published in Cancer drug resistance (01.01.2021)
Get full text
Journal Article
Loading…
Mechanisms of chemotherapy resistance in ovarian cancer
Ortiz, Mylena, Wabel, Emma, Mitchell, Kerry, Horibata, Sachi
Published in Cancer drug resistance (01.01.2022)
Published in Cancer drug resistance (01.01.2022)
Get full text
Journal Article
Loading…
Loading…
Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer
Rinne, Natasha, Christie, Elizabeth L, Ardasheva, Anastasia, Kwok, Chun Hei, Demchenko, Nikita, Low, Caroline, Tralau-Stewart, Catherine, Fotopoulou, Christina, Cunnea, Paula
Published in Cancer drug resistance (01.01.2021)
Published in Cancer drug resistance (01.01.2021)
Get full text
Journal Article
Loading…
Loading…
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
Ulldemolins, Anna, Seras-Franzoso, Joaquin, Andrade, Fernanda, Rafael, Diana, Abasolo, Ibane, Gener, Petra, Schwartz, Jr, Simo
Published in Cancer drug resistance (01.01.2021)
Published in Cancer drug resistance (01.01.2021)
Get full text
Journal Article
Loading…
Loading…
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
Sun, Xiangyu, Zhao, Ping, Lin, Jierou, Chen, Kun, Shen, Jianliang
Published in Cancer drug resistance (01.01.2023)
Published in Cancer drug resistance (01.01.2023)
Get full text
Journal Article
Loading…
Regulation of cancer stem cells in triple negative breast cancer
Fultang, Norman, Chakraborty, Madhuparna, Peethambaran, Bela
Published in Cancer drug resistance (01.01.2021)
Published in Cancer drug resistance (01.01.2021)
Get full text
Journal Article
Loading…
The roles of the human ATP-binding cassette transporters P-glycoprotein and ABCG2 in multidrug resistance in cancer and at endogenous sites: future opportunities for structure-based drug design of inhibitors
Goebel, Jason, Chmielewski, Jean, Hrycyna, Christine A
Published in Cancer drug resistance (01.01.2021)
Published in Cancer drug resistance (01.01.2021)
Get full text
Journal Article
Loading…
Loading…
Loading…
Drug resistance in glioblastoma: are persisters the key to therapy?
Oliver, Lisa, Lalier, Lisenn, Salaud, Céline, Heymann, Dominique, Cartron, Pierre François, Vallette, François M
Published in Cancer drug resistance (01.01.2020)
Published in Cancer drug resistance (01.01.2020)
Get full text
Journal Article
Loading…
Cell-mediated and cell membrane-coated nanoparticles for drug delivery and cancer therapy
Yaman, Serkan, Chintapula, Uday, Rodriguez, Edgar, Ramachandramoorthy, Harish, Nguyen, Kytai T
Published in Cancer drug resistance (01.01.2020)
Published in Cancer drug resistance (01.01.2020)
Get full text
Journal Article
Loading…
Loading…
A review of mechanisms of resistance to immune checkpoint inhibitors and potential strategies for therapy
Fujiwara, Yu, Mittra, Arjun, Naqash, Abdul Rafeh, Takebe, Naoko
Published in Cancer drug resistance (01.01.2020)
Published in Cancer drug resistance (01.01.2020)
Get full text
Journal Article
Loading…
HDAC inhibitors with potential to overcome drug resistance in castration-resistant prostate cancer
Biersack, Bernhard, Nitzsche, Bianca, Höpfner, Michael
Published in Cancer drug resistance (01.01.2022)
Published in Cancer drug resistance (01.01.2022)
Get full text
Journal Article
Loading…
Loading…
Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer
Zhang, Haiyun, Steed, Alexander, Co, Milo, Chen, Xiaozhuo
Published in Cancer drug resistance (01.01.2021)
Published in Cancer drug resistance (01.01.2021)
Get full text
Journal Article